JP2013526863A - バイオマーカーとして用いるための不連続状態 - Google Patents

バイオマーカーとして用いるための不連続状態 Download PDF

Info

Publication number
JP2013526863A
JP2013526863A JP2013509571A JP2013509571A JP2013526863A JP 2013526863 A JP2013526863 A JP 2013526863A JP 2013509571 A JP2013509571 A JP 2013509571A JP 2013509571 A JP2013509571 A JP 2013509571A JP 2013526863 A JP2013526863 A JP 2013526863A
Authority
JP
Japan
Prior art keywords
disease
discontinuous
genes
cell carcinoma
signature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013509571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013526863A5 (https=
Inventor
ベロイト，マンフレッド
シュラムル，ペーター
モチ，ホルガー
ボウディス，ミッチェル
シメルマン，フィリップ
グルイスセム，ウィルヘルム
ヘンコ，カルステン
Original Assignee
ユニバーシテート チューリッヒ
イーティーエイチ・チューリッヒ
パレク アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシテート チューリッヒ, イーティーエイチ・チューリッヒ, パレク アーゲー filed Critical ユニバーシテート チューリッヒ
Publication of JP2013526863A publication Critical patent/JP2013526863A/ja
Publication of JP2013526863A5 publication Critical patent/JP2013526863A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2013509571A 2010-05-13 2011-05-12 バイオマーカーとして用いるための不連続状態 Withdrawn JP2013526863A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33431810P 2010-05-13 2010-05-13
EP10162783.4 2010-05-13
EP10162783 2010-05-13
US61/334,318 2010-05-13
PCT/EP2011/057691 WO2011141544A1 (en) 2010-05-13 2011-05-12 Discrete states for use as biomarkers

Publications (2)

Publication Number Publication Date
JP2013526863A true JP2013526863A (ja) 2013-06-27
JP2013526863A5 JP2013526863A5 (https=) 2014-06-19

Family

ID=43127799

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013509571A Withdrawn JP2013526863A (ja) 2010-05-13 2011-05-12 バイオマーカーとして用いるための不連続状態

Country Status (5)

Country Link
US (1) US20130157887A1 (https=)
EP (1) EP2569636A1 (https=)
JP (1) JP2013526863A (https=)
CA (1) CA2798434A1 (https=)
WO (1) WO2011141544A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
JP5308328B2 (ja) 2006-04-04 2013-10-09 シングレックス，インコーポレイテッド トロポニンの分析のための高感度のシステムおよび方法
WO2010144358A1 (en) 2009-06-08 2010-12-16 Singulex, Inc. Highly sensitive biomarker panels
EP3722444B1 (en) * 2019-04-12 2024-06-05 Robert Bosch Gesellschaft für medizinische Forschung mbH Method for determining rcc subtypes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008128043A2 (en) * 2007-04-11 2008-10-23 The General Hospital Corporation Diagnostic and prognostic methods for renal cell carcinoma
JP2008544223A (ja) * 2005-06-08 2008-12-04 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 癌治療を受けている患者の同定、判定および処置のための方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008544223A (ja) * 2005-06-08 2008-12-04 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 癌治療を受けている患者の同定、判定および処置のための方法
WO2008128043A2 (en) * 2007-04-11 2008-10-23 The General Hospital Corporation Diagnostic and prognostic methods for renal cell carcinoma

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6015020736; Ｃｌｉｎｉｃａｌ　Ｃａｎｃｅｒ　Ｒｅｓｅａｒｃｈ Ｖｏｌ．１１，　Ｎｏ．１６, 2005, ｐ．５７３０-５７３９ *
JPN6015020738; Ｈｉｓｔｏｐａｔｈｏｌｏｇｙ Ｖｏｌ．５５, 2009, ｐ．６８７-６９５ *
JPN6015020741; ＢＭＣ　Ｃａｎｃｅｒ Ｖｏｌ．３，　Ｎｏ．３１, 2003, ｐ．１-１９ *

Also Published As

Publication number Publication date
EP2569636A1 (en) 2013-03-20
CA2798434A1 (en) 2011-11-17
WO2011141544A1 (en) 2011-11-17
US20130157887A1 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
JP7169002B2 (ja) 癌の検出のための血漿ｄｎａ中のサイズ及び数異常の使用
Lau et al. Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing
Modlin et al. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms
JP6140202B2 (ja) 乳癌の予後を予測するための遺伝子発現プロフィール
CN103733065B (zh) 用于癌症的分子诊断试验
Herbst et al. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
Singhal et al. Gene expression profiling of non-small cell lung cancer
US20100099093A1 (en) Biomarkers for the Identification Monitoring and Treatment of Head and Neck Cancer
Cheng et al. SUVA: splicing site usage variation analysis from RNA-seq data reveals highly conserved complex splicing biomarkers in liver cancer
Wu et al. DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma
JP2007049991A (ja) 乳癌の骨への再発の予測
CN113544288B (zh) 用于预测肝癌复发的dna甲基化标志物及其用途
Aghamaleki et al. Application of an artificial neural network in the diagnosis of chronic lymphocytic leukemia
EP2997163A1 (en) Methods to predict risk of recurrence in node-positive early breast cancer
CA2753971C (en) Accelerated progression relapse test
JP2013526863A (ja) バイオマーカーとして用いるための不連続状態
Zhang et al. Identification of driver genes and somatic mutations in cell‐free DNA of patients with pulmonary lymphangioleiomyomatosis
Gordon Transcriptional profiling of mesothelioma using microarrays
Gevaert et al. Prediction of cancer outcome using DNA microarray technology: past, present and future
CN101365950B (zh) 用于鉴别原发起源不明癌的起源的方法和材料
Campbell et al. Applying gene expression microarrays to pulmonary disease
Jørgensen et al. Untangling the intracellular signalling network in cancer—A strategy for data integration in acute myeloid leukaemia
WO2025061097A9 (en) Uses of cell-free dna fragmentation patterns associated with epigenetic modifications
Li et al. Integrated multi-omics analysis reveals comprehensive metabolism-driven tumor heterogeneity and immune microenvironment in hepatocellular carcinomas
Lu et al. Identification of Key Genes via Integrated Multi-Omics and Machine Learning Uncovers Tumor Biological Features and Prognostic Biomarkers in Uterine Leiomyosarcoma

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140424

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140424

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20141205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150526

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151222